vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and High Tide Inc. (HITI). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $142.5M, roughly 1.9× High Tide Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -1.9%, a 3.2% gap on every dollar of revenue.
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
High Tide Inc. is a Canada-based consumer retail and lifestyle company focused on the global cannabis sector. It operates a large network of licensed cannabis dispensaries across North America, sells cannabis consumption accessories and branded cannabis products, and runs multiple leading e-commerce platforms catering to recreational and medical cannabis users.
ACAD vs HITI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $142.5M |
| Net Profit | $3.6M | $-2.7M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 0.0% |
| Net Margin | 1.4% | -1.9% |
| Revenue YoY | 9.7% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $142.5M | ||
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $131.7M | ||
| Q2 25 | $264.6M | $124.3M | ||
| Q1 25 | $244.3M | — | ||
| Q4 24 | $259.6M | $128.1M | ||
| Q3 24 | $250.4M | — | ||
| Q2 24 | $242.0M | — |
| Q1 26 | $3.6M | $-2.7M | ||
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $991.0K | ||
| Q2 25 | $26.7M | $166.0K | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | — | ||
| Q2 24 | $33.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | 26.9% | ||
| Q2 25 | 92.2% | 28.4% | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | 28.1% | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | 0.0% | ||
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 2.3% | ||
| Q2 25 | 12.2% | 1.6% | ||
| Q1 25 | 7.9% | — | ||
| Q4 24 | 59.1% | 2.2% | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 12.6% | — |
| Q1 26 | 1.4% | -1.9% | ||
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 0.8% | ||
| Q2 25 | 10.1% | 0.1% | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | — | ||
| Q2 24 | 13.8% | — |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | — | ||
| Q2 25 | $0.16 | — | ||
| Q1 25 | $0.11 | — | ||
| Q4 24 | $0.86 | — | ||
| Q3 24 | $0.20 | — | ||
| Q2 24 | $0.20 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
